インドリノン化合物を用いる急性骨髄性白血病の治療

Title:

インドリノン化合物を用いる急性骨髄性白血病の治療

Document Type and Number:

Japanese Patent JP2005511540

Kind Code:

A

Abstract:

A method of treating acute myeloid leukemia in patient positive for FLT-3-ITD is described. The treatment is accomplished by administration of a compound of Formula I or II as defined herein.

More Like This:

JP2016147833	INDOLE COMPOUND AND CELL REPAIR AGENT CONTAINING SAID COMPOUND
WO/2000/038519	3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATING PROTEIN KINASE ACTIVITY AND FOR USE IN CANCER CHEMOTHERAPY
JP4516316	Fluoride 4-azasteroid derivative as an androgen receptor modulator

Inventors:

Ann Farrell, Anne-Marie
Charrington, Julie

Application Number:

JP2003537578A

Publication Date:

April 28, 2005

Filing Date:

October 28, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SUGEN,INC.

International Classes:

A61K31/404; A61K31/4192; A61K31/5377; A61P35/00; A61P43/00; C07D403/06; C07D403/14; C07D473/00; C07D401/14; A61K; (IPC1-7): A61K31/5377; A61K31/404; A61K31/4192; A61P35/00; A61P43/00; C07D401/14

Attorney, Agent or Firm:

Seiji Ohno
Koji Morita
Reiko Tanaka
Ken Kitano

Previous Patent: JP2005511539

Next Patent: プロリン後切断プロテアーゼの阻害剤